Case Study
Science 37 Accelerates Timelines and Expands Reach in Infectious Disease Study.
Science 37
Science 37
With nearly a decade of experience delivering hybrid and decentralized clinical trials, Science 37 brings together the end-to-end infrastructure and clinical expertise to deliver the full spectrum of remote research, while providing the flexibility to meet evolving patient and investigator needs.
Research Excellence Across Therapeutic Areas.
A uniquely patient-friendly model makes the Science 37 Metasite™ more than a decentralized clinical trial platform. It’s an engine that drives a new breed of research by bringing clinical trials into patient homes.
This “at home” advantage fuels study innovation across therapeutic areas.
In-home spirometry for an asthma trial
At-home infusions for a postpartum depression study
Remote dermatology image capture for AI tools
Virtual SLEDAI/ESSDAI at home
25-foot walk tests at-home with an expert mobile rater
The decentralized arm for a Phase III atrial fibrillation trial
Deliver Results and Meet Clinical Trial Goals.
Science 37 accelerates patient recruitment and improves retention through expansive reach and access beyond research sites. Recent case study highlights provide a glimpse into the possibilities for your remote clinical research:
12,000
participants enrolled across 49 U.S. states in one study
2,000+
home nursing visits for an oncology study, without a single missed visit
25,000
medical records collected for a diagnostic screening study
Science 37 Delivers Results.
“[The Science 37] Metasite™ strategy complements the conventional site mix to accelerate the recruitment of patients in remote locations and in underrepresented communities.”
IDC Real-World Evidence, Social Determinants of Health, and Digital Biomarkers in Driving Patient Recruitment, #US50382823, March 2023
“Science 37 places a significant emphasis on training. Healthcare staff are trained on the platform used in clinical trials, ensuring that when the patient and provider come into contact during any DCT, the patient experience is easy, and the data collected is accurate.”
GlobalData
“Science 37 delivers a model that truly supports patient preference—providing access through the site or through a DCT model. The patient’s choice is front and center.”
Clinical Trial Sponsor
“Science 37 allows us to enroll patients who don’t traditionally participate in trials, decreasing burden on patients and site, improving diversity and reach.”
Clinical Trial Sponsor
Clinical Trial Models That We Deliver
- A Single, Virtual Site—The Science 37 Metasite™ delivers the end-to-end decentralized clinical trial as a single site that reaches patients regardless of location.
- One Site of Many; Enabling Research Sites—The Science 37 Metasite™ works alongside research sites on the same trial. Sites use the Science 37 unified platform for data capture—enabling standardized data across the trial.
- Hybrid Trials—This blend of Metasite™, Community Providers and Research Sites, allows for a portion of visits to be remote—decreasing patient burden.
Clinical Trial Models That We Deliver
- A Single, Virtual Site—The Science 37 Metasite™ delivers the end-to-end decentralized clinical trial as a single site that reaches patients regardless of location.
- One Site of Many; Enabling Research Sites—The Science 37 Metasite™ works alongside research sites on the same trial. Sites use the Science 37 unified platform for data capture—enabling standardized data across the trial.
- Hybrid Trials—This blend of Metasite™, Community Providers and Research Sites, allows for a portion of visits to be remote—decreasing patient burden.